Development of ZMYM2-FGFR1 driven AML in human CD34+ cells in immunocompromised mice: Model of ZMYM2-FGFR1 driven AML

Full text: Download

Publisher: Wiley (12 months)

Preprint: archiving allowed. Upload

Postprint: archiving restricted: Upload

  • 12 months embargo

Published version: archiving forbidden. Upload

Policy details (opens in a new window). Data provided by SHERPA/RoMEO